cyclohexanol has been researched along with Birth Weight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Källén, B; Lennestål, R | 1 |
Altenburg, SP; da-Silva, VA; Lindsey, CJ; Malheiros, LR; Thomaz, TG | 1 |
Addis, A; Brochu, J; Chambers, C; Einarson, A; Einarson, TR; Fatoye, B; Koren, G; Lavigne, SV; Mastroiacovo, P; Matsui, D; Sarkar, M; Schuler, L | 1 |
3 other study(ies) available for cyclohexanol and Birth Weight
Article | Year |
---|---|
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride | 2007 |
Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Birth Weight; Body Weight; Cyclohexanols; Female; Fluoxetine; Growth; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Weight Gain | 1999 |
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Birth Weight; Cyclohexanols; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking; Venlafaxine Hydrochloride | 2001 |